Search
Aurinia Pharmaceuticals Inc
AUPHAdd to Watchlist
14.880USD
-0.120-0.80%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.91BMarket Cap
6.68P/E TTM
Aurinia Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Aurinia Pharmaceuticals Inc is 6.89, ranking 243 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 6.68, which is 3245.33% below the recent high of 223.33 and 1095.45% above the recent low of -66.45.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.